Clinical trial

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

NCT01808612

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-03-01

PhasePHASE3

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2015-05-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

FluoxetineDRUG · verified · RxNorm: fluoxetine

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

TokyoJapan1 OsakaJapan1 FukuokaJapan1 KyotoJapan1 ChibaJapan1 HiroshimaJapan1 OkayamaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01808612 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.